Trial Profile
Evaluation of Dexamethasone Phosphate Delivered by Ocular Iontophoresis for the Treatment of Dry Eye in the Controlled Adverse Environment (CAE) Model
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Sep 2022
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors EyeGate Pharma; Kiora Pharmaceuticals
- 14 May 2014 New trial record